最近搜索:細胞培養 微生物學 分子生物 生物化學
    首頁>>免疫學>>一抗>>磷酸化過氧化酶活化增生受體γ抗體 PPARγ
    磷酸化過氧化酶活化增生受體γ抗體 PPARγ
    • 產品貨號:
      BN41022R
    • 中文名稱:
      磷酸化過氧化酶活化增生受體γ抗體 PPARγ
    • 英文名稱:
      Rabbit anti-Phospho-PPAR Gamma (ser273) Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產品規格

      售價

      備注

    • BN41022R-100ul

      100ul

      ¥2470.00

      交叉反應:Human,Mouse(predicted:Rat,Chicken,Pig,Cow,Rabbit,Sheep) 推薦應用:WB,IHC-P,IHC-F,ICC,IF,ELISA

    產品描述

    英文名稱Phospho-PPAR Gamma (ser273)
    中文名稱磷酸化過氧化酶活化增生受體γ抗體 PPARγ
    別    名Phospho-PPAR Gamma(ser273); P-PPAR Gamma (Phospho-ser273); CIMT1; HUMPPARG; NR1C3; Nuclear receptor subfamily 1 group C member 3; PAX8/PPARG Fusion Gene; Peroxisome Proliferator Activated Receptor gamma; PPAR gamma; PPARG; PPARG1; PPARG2; PPARG3; PPARG_HUMAN.  



    產品類型磷酸化抗體 
    研究領域腫瘤  細胞生物  信號轉導  細胞凋亡  激酶和磷酸酶  表觀遺傳學  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應Human, Mouse,  (predicted: Rat, Chicken, Pig, Cow, Rabbit, Sheep, )
    產品應用WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100 IF=1:100-500 (石蠟切片需做抗原修復)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量57kDa
    細胞定位細胞核 細胞漿 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthesised phosphopeptide derived from human PPAR Gamma around the phosphorylation site of ser273:DK(p-S)PF 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產品介紹This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described.

    Function:
    Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis.

    Subunit:
    Forms a heterodimer with the retinoic acid receptor RXRA called adipocyte-specific transcription factor ARF6. Interacts with NCOA6 coactivator, leading to a strong increase in transcription of target genes. Interacts with coactivator PPARBP, leading to a mild increase in transcription of target genes. Interacts with FAM120B. Interacts with PRDM16 (By similarity). Interacts with NOCA7 in a ligand-inducible manner. Interacts with NCOA1 LXXLL motifs. Interacts with DNTTIP2, MAP2K1/MEK1, PRMT2 and TGFB1I1. Interacts with PDPK1. Interacts with ASXL1 AND ASXL2.

    Subcellular Location:
    Nucleus. Cytoplasm.

    Tissue Specificity:
    Highest expression in adipose tissue. Lower in skeletal muscle, spleen, heart and liver. Also detectable in placenta, lung and ovary.

    DISEASE:
    Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer.
    Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:601665]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.
    Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:604367]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.
    Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:137800]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility.

    Similarity:
    Belongs to the nuclear hormone receptor family. NR1 subfamily.
    Contains 1 nuclear receptor DNA-binding domain.

    SWISS:
    P37231

    Gene ID:
    5468

    Database links:

    Entrez Gene: 5468 Human

    Entrez Gene: 19016 Mouse

    Entrez Gene: 25664 Rat

    SwissProt: P37231 Human

    SwissProt: P37238 Mouse

    SwissProt: O88275 Rat

    Unigene: 162646 Human

    Unigene: 3020 Mouse

    Unigene: 23443 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.


    国产亚洲精品自在久久| 亚洲伊人久久大香线蕉AV| 亚洲精品中文字幕无码A片老| 久久精品国产亚洲精品2020| 国产亚洲人成网站观看| 亚洲愉拍99热成人精品热久久| 亚洲性日韩精品一区二区三区| 亚洲国产人成中文幕一级二级| 亚洲成a人片在线观看国产| 亚洲国产成人乱码精品女人久久久不卡 | 亚洲一区二区三区久久久久| 亚洲午夜在线一区| 亚洲mv国产精品mv日本mv| 精品亚洲成A人无码成A在线观看| 亚洲一区在线免费观看| 国产精品亚洲一区二区麻豆| 亚洲欧美日韩中文字幕一区二区三区| 亚洲国产中文在线视频| 亚洲成A人片在线播放器| 亚洲日韩精品A∨片无码加勒比 | 久久99亚洲综合精品首页| 亚洲中文字幕久久精品无码喷水 | 亚洲综合一区二区三区四区五区| 亚洲七久久之综合七久久| 韩国亚洲伊人久久综合影院| 亚洲国产a级视频| 亚洲熟女少妇一区二区| 亚洲a在线视频视频| 亚洲网红精品大秀在线观看| 亚洲最新黄色网址| 亚洲熟妇无码一区二区三区| 精品无码专区亚洲| 国产亚洲人成网站在线观看| 久久精品国产亚洲AV麻豆王友容| 久久亚洲熟女cc98cm| 亚洲黄色激情视频| 国产成人va亚洲电影| 永久亚洲成a人片777777| 亚洲欧洲国产精品你懂的| 亚洲人成免费网站| 黑人粗长大战亚洲女2021国产精品成人免费视频 |